Profile | GDS4284 / 78047_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2069.18 | 84 |
GSM687648 | Patient 402 control | 2471.8 | 86 |
GSM687653 | Patient 403 control | 1803.64 | 83 |
GSM687658 | Patient 404 control | 2047.8 | 84 |
GSM687663 | Patient 411 control | 2672.59 | 88 |
GSM687668 | Patient 422 control | 2686.31 | 87 |
GSM687673 | Patient 424 control | 2590.33 | 87 |
GSM687678 | Patient 425 control | 1760.03 | 82 |
GSM687683 | Patient 427 control | 2504.95 | 87 |
GSM687688 | Patient 428 control | 2035.63 | 84 |
GSM687695 | Patient 441 control | 7491.41 | 96 |
GSM687699 | Patient 443 control | 2536.7 | 87 |
GSM687704 | Patient 444 control | 2706.1 | 88 |
GSM687707 | Patient 448 control | 1901.33 | 84 |
GSM687712 | Patient 449 control | 1560.48 | 81 |
GSM687719 | Patient 450 control | 2705.07 | 88 |
GSM687724 | Patient 451 control | 2634.58 | 87 |
GSM687728 | Patient 452 control | 2468.14 | 87 |
GSM687646 | Patient 401 treated 24h | 1732.5 | 82 |
GSM687649 | Patient 402 treated 24h | 2634.45 | 87 |
GSM687665 | Patient 411 treated 24h | 2719.7 | 88 |
GSM687651 | Patient 402 treated 4 weeks | 2475.45 | 87 |
GSM687667 | Patient 411 treated 4 weeks | 2050.16 | 84 |
GSM687670 | Patient 422 treated 24h | 2401.06 | 86 |
GSM687671 | Patient 422 treated 4 weeks | 2459.4 | 86 |
GSM687654 | Patient 403 treated 24h | 1792.19 | 82 |
GSM687675 | Patient 424 treated 24h | 2191.86 | 85 |
GSM687685 | Patient 427 treated 24h | 2461.67 | 86 |
GSM687656 | Patient 403 treated 4 weeks | 1794.47 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 2078.62 | 84 |
GSM687687 | Patient 427 treated 4 weeks | 1547.78 | 80 |
GSM687692 | Patient 428 treated 4h | 1896.41 | 83 |
GSM687716 | Patient 449 treated 4h | 1566.49 | 80 |
GSM687722 | Patient 450 treated 4h | 3575.15 | 91 |
GSM687680 | Patient 425 treated 24h | 1557.63 | 80 |
GSM687690 | Patient 428 treated 24h | 2076.4 | 84 |
GSM687700 | Patient 443 treated 24h | 4429.62 | 93 |
GSM687705 | Patient 444 treated 24h | 2097.47 | 85 |
GSM687714 | Patient 449 treated 24h | 2130.2 | 85 |
GSM687721 | Patient 450 treated 24h | 3751.99 | 91 |
GSM687682 | Patient 425 treated 4 weeks | 1565.7 | 81 |
GSM687694 | Patient 428 treated 4 weeks | 1640.82 | 81 |
GSM687702 | Patient 443 treated 4 weeks | 2524.09 | 87 |
GSM687718 | Patient 449 treated 4 weeks | 1556.63 | 81 |
GSM687723 | Patient 450 treated 4 weeks | 2126.63 | 85 |
GSM687661 | Patient 404 treated 4h | 2425.93 | 86 |
GSM687710 | Patient 448 treated 4h | 1772.92 | 83 |
GSM687726 | Patient 451 treated 4h | 2610.34 | 87 |
GSM687730 | Patient 452 treated 4h | 5877.47 | 95 |
GSM687660 | Patient 404 treated 24h | 4451.55 | 93 |
GSM687697 | Patient 441 treated 24h | 4419.87 | 93 |
GSM687709 | Patient 448 treated 24h | 1391.04 | 79 |
GSM687725 | Patient 451 treated 24h | 2961.98 | 89 |
GSM687729 | Patient 452 treated 24h | 4236.84 | 92 |
GSM687727 | Patient 451 treated 4 weeks | 1871.52 | 83 |
GSM687731 | Patient 452 treated 4 weeks | 2830.22 | 88 |